Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesUS, Europe filings to drive Biocon growth: Kiran Mazumdar-Shaw

SHOW NAMES

Trending Topics

business

US, Europe filings to drive Biocon growth: Kiran Mazumdar-Shaw

These market filings have a market opportunity of USD 40 billion. In particular, Japan offers a market potential of USD 150 million for its insulin product Glargine, says Biocon's Chairman and Managing Director.

first published: May 24, 2016 10:11 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347